DEFITELIO® is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstructive syndrome (SOS) in hematopoietic stem-cell transplantation (HSCT) therapy. It is indicated in adults and in adolescents, children, and infants over 1 month of age.

For full details please refer to the PI as approved by the IL MoH.